Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new collaboration between Oxford, Brazil and Pakistan has been funded by the Bill & Melinda Gates Foundation. The partnership will provide researchers with de-identified health data from two of the worlds global COVID-19 hotspots to increase understanding of COVID-19 in these communities and help accelerate the management of the disease.

Global covid map

The COVID-19 pandemic has placed an unprecedented burden on global healthcare systems, particularly in under-resourced communities. The COVID-19 death rate in Brazil made it the second worst hit country in the world in 2020, and South Asia, home to a quarter of the world's population, is a COVID-19 hotspot. South Asian ethnicity is associated with a high risk of severe COVID-19 and related mortality however, there has been little or no real-world COVID-19 data analysis from South Asia or Brazil to explain the risk factors.

New funding from the Bill & Melinda Gates Foundation (the foundation) brings together researchers from the University of Oxford, with CIDACS (the Brazilian centre for big health data) and the Shaukat Khanum Memorial Hospital and Research Centre (SKMCH&RC) in Pakistan. Each institute holds large numbers of health records from patients in Brazil and Pakistan and these databases will be used to analyse the natural history of COVID-19 and characterise the disease to help inform decision-making around the care of hospitalised patients.

The initiative is led by Dr Sara Khalid, Senior Research Fellow in Biomedical Data Science and Health Informatics, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS).

Read the full story on the NDORMS website

Similar stories

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.